EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 52023AE0215

Opinion of the European Economic and Social Committee on ‘Proposal for a Regulation of the European Parliament and of the Council on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) No 658/2014 of the European Parliament and of the Council’ (COM(2022) 721 final — 2022/0417 (COD))

EESC 2023/00215

OJ C 140, 21.4.2023, p. 85–85 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

21.4.2023   

EN

Official Journal of the European Union

C 140/85


Opinion of the European Economic and Social Committee on ‘Proposal for a Regulation of the European Parliament and of the Council on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) No 658/2014 of the European Parliament and of the Council’

(COM(2022) 721 final — 2022/0417 (COD))

(2023/C 140/15)

Referral

Council of the European Union, 22.12.2022

European Parliament, 15.12.2022

Legal basis

Article 114 and Article 168(4)(c) and (b) of the Treaty on the Functioning of the European Union

Section responsible

Single Market, Production and Consumption

Adopted at plenary

24.1.2023

Plenary session No

575

Outcome of vote

(for/against/abstentions)

195/0/1

Since the Committee unreservedly endorses the proposal and feels that it requires no comment on its part, it has decided to issue an opinion endorsing the proposed text.

Brussels, 24 January 2023.

The President of the European Economic and Social Committee

Christa SCHWENG


Top